Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Potential pharmacokinetic interactions with concurrent use of herbal medicines and a ritonavir-boosted COVID-19 protease inhibitor in low and middle-income countries.
Smith DJ, Bi H, Hamman J, Ma X, Mitchell C, Nyirenda K, Monera-Penduka T, Oketch-Rabah H, Paine MF, Pettit S, Pheiffer W, Van Breemen RB, Embry M. Smith DJ, et al. Among authors: hamman j. Front Pharmacol. 2023 Jul 12;14:1210579. doi: 10.3389/fphar.2023.1210579. eCollection 2023. Front Pharmacol. 2023. PMID: 37502215 Free PMC article. Review.
What are the dangers of drug interactions with herbal medicines?
Gouws C, Hamman JH. Gouws C, et al. Expert Opin Drug Metab Toxicol. 2020 Mar;16(3):165-167. doi: 10.1080/17425255.2020.1733969. Epub 2020 Feb 25. Expert Opin Drug Metab Toxicol. 2020. PMID: 32079422 No abstract available.
Herb-drug pharmacokinetic interactions reviewed.
Tarirai C, Viljoen AM, Hamman JH. Tarirai C, et al. Expert Opin Drug Metab Toxicol. 2010 Dec;6(12):1515-38. doi: 10.1517/17425255.2010.529129. Epub 2010 Nov 11. Expert Opin Drug Metab Toxicol. 2010. PMID: 21067427 Review.
142 results